Vivos Therapeutics, Inc. Notes Receivable, Related Parties
Vivos Therapeutics, Inc. (VVOS) had Notes Receivable, Related Parties of $1.20 million as of 2019-10-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Receivables
us-gaap:NotesReceivableRelatedParties · last filed 2022-03-31
- 2019-10-31: Notes Receivable, Related Parties $1.20M.
| Period end | Notes Receivable, Related Parties |
|---|---|
| 2019-10-31 | $1.20M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |